Cbd And Hemp

Caution replaces euphoria as hemp event attendees wrestle with changing market

29-Mar-2021 By Hank Schultz

The CBD/hemp markets, both in finished goods and on the supply side, are in a state of transition, attendees at an industry event learned on Friday. The message was that some growers and some finished product marketers are likely to fall by the wayside...

FDA warns CBD companies about illegal pain treatment claims

23-Mar-2021 By Hank Schultz

The US Food and Drug Administration has sent out warnings against companies claiming to relieve pain with products containing CBD.

NPA, others support CA CBD bill while still advocating for federal solution

11-Mar-2021 By Hank Schultz

Yesterday the Natural Products Association testified in favor of a California bill to regulate the CBD trade in that state. NPA and others, however, have reiterated a call for federal legislation that would forestall the growing patchwork quilt of state...

Industry group clarifies hemp definition in wake of Delta-8 THC confusion

10-Mar-2021 By Hank Schultz

Recent news reports about the marketing of products featuring Delta-8 THC as a prominent constituent have muddied the waters enough that the US Hemp Roundtable felt it necessary to clarify again what should—and shouldn’t—be called a hemp product.

NFL seeks info on study of CBD to alleviate players’ chronic pain

25-Feb-2021 By Hank Schultz

The National Football League and its players are seeking information from researchers on the use of CBD for pain relief. The hope is to lessen the use of opiates for the purpose.

New US Hemp Authority standard spells out ‘broad’ and ‘full spectrum’ specs

22-Feb-2021 By Hank Schultz

The US Hemp Authority has released the latest version of its certification standard whose aim is to promote best practices and heighten transparency among hemp companies.

Pandemic boosts pet ownership, supercharges supplement market

18-Jan-2021 By Hank Schultz

The pandemic has boosted pet ownership and has dramatically expanded the market for pet supplements, an executive says. And when those new pet owners reach for a supplement, it’s likely to be one that contains CBD.

NPA urges FDA to stem tide of counterfeit products, move forward on CBD

07-Jan-2021 By Hank Schultz

Federal regulators could do more to protect consumers by using existing import authorities as well as moving forward on hemp/CBD regulation, the National Products Association has said.

FTC enforcement action targets six CBD firms over unsubstantiated claims

17-Dec-2020 By Hank Schultz

The Federal Trade Commission unveiled an enforcement action today against six sellers of CBD products that it alleges have been making unsubstantiated disease treatment claims. FTC has levied more than $246,000 in fines in the cases.

The Vitamin Shoppe expands private brand portfolio with new CBD hemp brands

17-Nov-2020 By Danielle Masterson

The Vitamin Shoppe launched its first proprietary CBD hemp extract products under its Full Spectrum plnt and Broad Spectrum Vthrive The Vitamin Shoppe Brands, marking the retailer’s continued expansion of its private brands portfolio in the CBD category....

CV Sciences further differentiates line with addition of PEA-based immune health product

02-Oct-2020 By Hank Schultz

New immune health launches are helping CV Sciences transform itself into a broader based supplement brand, company officials said recently.

CBD news: New extraction facility; products planned for Latin American markets

01-Oct-2020 By Hank Schultz

A new extraction facility is about to come online in Florida, while at the same time a California company is planning a launch of CBD products in Brazil and Uruguay.

Hemp, cacao fruit, gourmet CBD and more surprises in September

30-Sep-2020 By Danielle Masterson

This month, Martha Stewart ditched the fancy desserts for gourmet gummies, seasonal probiotics for the whole family are now available and cacao fruit headlines a new wellness line.

GNC meets with White House office to advocate for CBD in supplements

30-Sep-2020 By Hank Schultz

GW Pharmaceuticals and supplement retailer GNC have reportedly been among the companies meeting recently with a White House division to discuss aspects of CBD regulation.

Recent upheavals put renewed emphasis on minority representation in cannabis/hemp sphere

14-Sep-2020 By Hank Schultz

The recent upheavals in the United States around race relations has the nation questioning the insidious role prejudice has played in many walks of life. One group is seeking to use that rekindled awareness as added leverage to ensure equal opportunity...

Despite raw material oversupply issues, hemp/CBD market forecast to grow strongly

28-Aug-2020 By Hank Schultz

Robust growth for the hemp/CBD sector was forecast during an online event hosted yesterday by the American Herbal Products Association.

CBD industry headed toward big overcapacity, expert asserts

24-Aug-2020 By Hank Schultz

The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.

Upcoming event aims to help fill regulatory holes in hemp/CBD industry

20-Aug-2020 By Hank Schultz

Nascent hemp/CBD firms are often woefully unprepared for the regulatory compliance side of operating a dietary supplement firm, something an upcoming industry event aims to help fix.

CBD for mood: Going green to ease the blues

19-Aug-2020 By Danielle Masterson

During these unprecedented times, many are undergoing a great amount of stress, leading many to seek out natural products to manage stress and boost their mood.

Folium Biosciences joins growing list of Colorado hemp heavyweights

17-Aug-2020 By Hank Schultz

The announcement by Colorado company Folium Biosciences of a large new extraction facility bolsters the state's position as a world leader in installed CBD extraction capacity.

CV Sciences’ revenue dives, but new products, increased distribution point to brighter future, company says

07-Aug-2020 By Hank Schultz

CBD manufacturer CV Sciences has reported a sharp drop in revenue, but company officials said wider distribution and new launches—including a product that contains no CBD—promise a bright future.

Advocates hopeful bill will pass this month to open California to CBD in supplements and foods

04-Aug-2020 By Hank Schultz

A bill before the California State legislature would open the country’s largest market to dietary supplements and foods containing CBD, but advocates say time is running out while the machinery of state government is preoccupied with pandemic concerns.

New high capacity Colorado CBD extractor enters market

31-Jul-2020 By Hank Schultz

Vantage Hemp, a new hemp/CBD processor, is entering the market with a high capacity facility nearing completion in Colorado.

Amendment to military funding bill would allow soldiers to openly use CBD products

24-Jul-2020 By Hank Schultz

An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...

FDA report details poor quality control, undisclosed THC in many CBD products

09-Jul-2020 By Hank Schultz

An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.

CBD body announces safety study consortium as Novel Foods crunch time looms

19-Jun-2020 By Oliver Morrison

Ahead of the UK Food Standards Agency’s 31 March 2021 deadline for CBD products to have a validated novel foods application, the Association for the Cannabinoid Industry (ACI), which works to create a safe, legal and well-regulated CBD market in the UK,...

Neptune makes progress on revenue front as company transition continues

15-Jun-2020 By Hank Schultz

Neptune Wellness Solutions reported a 21% rise in full year earnings. The Canadian company took in $21.7 million in its most recent fiscal year, compared to $17.9 million for the year previously.

CBD firms team up with CRO to conduct large scale safety study

10-Jun-2020 By Hank Schultz

A group of hemp/CBD purveyors have teamed up with a clinical research firm to conduct a large scale study to provide the safety data that the US Food and Drug Administration says it lacks.

CV Sciences highlights new research that touts CBD safety, benefits

02-Jun-2020 By Danielle Masterson

Hemp cannabidiol (CBD) supplier and manufacturer CV Sciences just announced fresh research that demonstrates the safety and health benefits of its PlusCBD products.

NutraCast Podcast: Kat Merryfield on CBG & CBN

22-May-2020 By Danielle Masterson

Brace yourself CBD, there are some other cannabinoids in town, and they may even steal the spotlight…

Canadian cannabis giant enters US market

21-May-2020 By Danielle Masterson

Canada's Aurora Cannabis Inc. just announced it will acquire American hemp retailer Reliva LLC. The duo expects to be positioned as a meaningful player in the United States, the world’s largest cannabinoid market.

Growing pains: Hemp industry deals with oversupply, shifting retail landscape

21-May-2020 By Danielle Masterson

The boom in hemp cultivation after the passage of the 2018 Farm Bill has created a supply bulge that the industry is still working through, observers say.

‘No CBD isolate’ and ‘zero THC’ claims indicative on ongoing regulatory uncertainty

21-May-2020 By Hank Schultz

New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’

Commentary

Research confirming consumers’ confusion points to yawning gap in CBD market surveillance

21-May-2020 By Hank Schultz

The ongoing CBD regulatory logjam has stunted the development of responsible, informative health claims for these products. I’ve speculated in these pages before that this will lead consumers to make it up as they go along. Two new studies seem to confirm...

Gencor’s Levagen ingredient sidesteps regulatory pitfalls on its way to endocannabinoid system

20-May-2020 By Hank Schultz

The regulatory issues that continue to cloud the CBD market have made room for alternative modes to affect the endocannabinoid system. Bolstered by recent bioavailability research, Gencor Pacifc thinks its Levagen PEA ingredient could be a winner.

Navigating PPP loans: Natural products industry weighs in

12-May-2020 By Danielle Masterson

A new survey out by the Natural Products Association (NPA) zeros in on the natural products industry and offers some insight into what the Paycheck Protection Program (PPP) process entails.

Texas proposes rules for consumable hemp products

11-May-2020 By Hank Schultz

The state of Texas has proposed rules for consumable hemp products that specify processing, testing, labeling and registration requirements. While the rules are characterized as reasonable and well thought out, they represent another patch in a state-by-state...